<bold> COMBINATION OF TUMOR TREATING FIELDS </bold>(TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS

被引:0
|
作者
Lazaridis, Lazaros [1 ]
Schaefer, Niklas [2 ]
Schmidt, Teresa [3 ]
Weller, Johannes [2 ]
Tzaridis, Theophilos-Dimitrios [2 ]
Scheffler, Bjoern [4 ]
Pierscianek, Daniela [5 ]
Kleinschnitz, Christoph [6 ]
Stuschke, Martin [7 ]
Sure, Ulrich [5 ]
Herrlinger, Ulrich [2 ]
Kebir, Sied [1 ]
Glas, Martin [3 ]
机构
[1] Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[2] Univ Bonn, Div Clin Neurooncol, Dept Neurol, Med Ctr, Bonn, Germany
[3] Univ Duisburg Essen, Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[4] Partner Site Univ Hosp Essen, German Canc Consortium DKTK, West German Canc Ctr WTZ, DKFZ,Div Translat Neurooncol, Essen, Germany
[5] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg, Essen, Germany
[6] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany
[7] Univ Duisburg Essen, Univ Hosp Essen, Dept Radiotherapy, Essen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
RARE-39
引用
收藏
页码:229 / 230
页数:2
相关论文
共 50 条
  • [41] Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma.
    Miller, Ryan C.
    Song, Andrew Jehyun
    Ali, Ayesha
    Bar-Ad, Voichita C.
    Martinez, Nina Leyson
    Glass, Jon
    Alnahhas, Iyad
    Andrews, David W.
    Judy, Kevin
    Evans, James J.
    Farrell, Christopher
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, Michele
    Palmer, Joshua David
    Liu, Haisong
    Shi, Wenyin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] SPARE TRIAL: SCALP-SPARING RADIATION WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Miller, Ryan
    Song, Andrew
    Ali, Ayesha S.
    Bar-Ad, Voichita
    Martinez, L.
    Glass, Jon
    Alnahhas, Iyad
    Andrews, David
    Judy, Kevin
    Evans, James
    Farrell, Christopher
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, May
    Palmer, Joshua
    Liu, Haisong
    Shi, Wenyin
    NEURO-ONCOLOGY, 2021, 23 : 43 - 44
  • [43] NCCTG phase I trial of temsirolimus (CCI-779) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients
    Sarkaria, J. N.
    Galanis, E.
    Wu, W.
    Giannini, C.
    Jaeckle, K. A.
    Doyle, L.
    Uhm, J.
    Brown, P.
    Dietz, A. B.
    Buckner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] FINAL ANALYSIS OF ACT III: A PHASE II TRIAL OF PF-04948568 (CDX-110) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lai, Rose K.
    Recht, Lawrence D.
    Reardon, David A.
    Paleologos, Nina
    Groves, Morris
    Rosenfeld, Myrna R.
    Meech, Sandra
    Davis, Tom
    Pavlov, Dmitri
    Marshall, Margaret A.
    Sampson, John
    NEURO-ONCOLOGY, 2010, 12 : 76 - 77
  • [45] Tumor treating fields treatment for patients with newly diagnosed glioblastoma: A cost-effectiveness analysis
    Guzauskas, Gregory F.
    Pollom, Erqi L.
    Stieber, Volker W.
    Wang, Bruce C.
    Garrison, Lou
    CANCER RESEARCH, 2018, 78 (13)
  • [46] TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nicholas, Garth A.
    Hirte, Holger
    Easaw, Jacob
    Muanza, Thierry
    Roberge, David
    Mathieu, David
    Pitz, Marshall
    NEURO-ONCOLOGY, 2017, 19 : 138 - 138
  • [47] EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma.
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel A.
    Nagpal, Seema
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Grossman, Rachel
    Glas, Martin
    CANCER RESEARCH, 2021, 81 (13)
  • [48] Concurrent Chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for Patients With Newly Diagnosed Glioblastoma May Increase the Rate of Distant Recurrence
    Ali, A.
    Niazi, M. Z. K.
    Bar-Ad, V.
    Werner-Wasik, M.
    Andrews, D. W.
    Farrell, C.
    Evans, J.
    Judy, K.
    Glass, J.
    Martinez, N.
    Alnahhas, I.
    Chervoneva, I.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E596 - E596
  • [49] CONCURRENT CHEMORADIATION AND TUMOR TREATING FIELDS (TTFIELDS, 200 KHZ) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MAY INCREASE THE RATE OF DISTANT RECURRENCE
    Ali, Ayesha S.
    Niazi, Muneeb
    Bar-Ad, Voichita
    Werner-Wasik, Maria
    Andrews, David
    Farrell, Christopher
    Evans, James
    Judy, Kevin
    Glass, Jon
    Martinez, Nina L.
    Alnahhas, Iyad
    Chervoneva, Inna
    Shi, Wenyin
    NEURO-ONCOLOGY, 2021, 23 : 63 - 63
  • [50] Real-world experience with tumor treating fields (TTFields) in newly diagnosed glioblastoma: A survival meta-analysis with systematic review
    Ballo, Matthew T.
    Conlon, Patrick
    Lavy-Shahaf, Gitit
    Urman, Noa
    Kinzel, Adrian
    Vymazal, Josef
    Rulseh, Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)